Empresa CytoDyn Inc. Other OTC
Acciones
CYDY
US23283M1018
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 65 | 17/11 | |
Mitchell Cohen
DFI | Director of Finance/CFO | 68 | 01/02 |
Scott Hansen
CTO | Chief Tech/Sci/R&D Officer | - | 03/05/23 |
Joseph Meidling
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/21 |
Melissa Palmer
CTO | Chief Tech/Sci/R&D Officer | - | 24/05/23 |
Cyrus Arman
COO | Chief Operating Officer | 43 | 09/07/22 |
Chief Tech/Sci/R&D Officer | 59 | 01/08/20 | |
Cristina de Leon
IRC | Investor Relations Contact | - | - |
Tyler Blok
LAW | General Counsel | 37 | 25/07/22 |
Seenu Srinivasan
LAW | General Counsel | - | 07/10/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Stephen Simes
BRD | Director/Board Member | 72 | 13/10/22 |
Ryan Dunlap
BRD | Director/Board Member | 54 | 24/08/22 |
Karen Brunke
BRD | Director/Board Member | 72 | 01/04/22 |
Lishomwa Ndhlovu
BRD | Director/Board Member | 54 | 24/11/21 |
Tanya Urbach
CHM | Chairman | 57 | 24/11/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 9 000 | 0 | 0 | 99,15 % |
Acción B | 0 | 6 000 | 0 | 0 | |
Acción C | 0 | 19 000 | 0 | 0 | |
Acción D | 1 | 993 809 000 | 985 393 715 ( 99,15 %) | 443 000 ( 0,0446 %) |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+8,96 % | 105 mil M | |
-1,43 % | 104 mil M | |
+4,40 % | 22,94 mil M | |
-12,15 % | 22,34 mil M | |
-4,36 % | 19,25 mil M | |
-39,98 % | 17,08 mil M | |
-10,04 % | 16,96 mil M | |
+6,79 % | 14,16 mil M | |
+38,61 % | 12,63 mil M |